Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA608386
Max Phase: Preclinical
Molecular Formula: C33H48N6O10S3
Molecular Weight: 784.98
Molecule Type: Protein
Associated Items:
ID: ALA608386
Max Phase: Preclinical
Molecular Formula: C33H48N6O10S3
Molecular Weight: 784.98
Molecule Type: Protein
Associated Items:
Canonical SMILES: CSCC[C@H](NC(=O)[C@H](CS)NC(=O)CNS(=O)(=O)c1cccc2c(N(C)C)cccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O
Standard InChI: InChI=1S/C33H48N6O10S3/c1-19(2)16-24(33(46)47)38-30(43)22(12-13-29(41)42)36-31(44)23(14-15-51-5)37-32(45)25(18-50)35-28(40)17-34-52(48,49)27-11-7-8-20-21(27)9-6-10-26(20)39(3)4/h6-11,19,22-25,34,50H,12-18H2,1-5H3,(H,35,40)(H,36,44)(H,37,45)(H,38,43)(H,41,42)(H,46,47)/t22-,23-,24-,25-/m0/s1
Standard InChI Key: YGJHULNBGIKILH-QORCZRPOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 784.98 | Molecular Weight (Monoisotopic): 784.2594 | AlogP: 0.80 | #Rotatable Bonds: 22 |
Polar Surface Area: 240.41 | Molecular Species: ACID | HBA: 11 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.50 | CX Basic pKa: 4.77 | CX LogP: -0.62 | CX LogD: -5.60 |
Aromatic Rings: 2 | Heavy Atoms: 52 | QED Weighted: 0.08 | Np Likeness Score: -0.59 |
1. Krzysiak AJ, Aditya AV, Hougland JL, Fierke CA, Gibbs RA.. (2010) Synthesis and screening of a CaaL peptide library versus FTase reveals a surprising number of substrates., 20 (2): [PMID:20005705] [10.1016/j.bmcl.2009.11.011] |
Source(1):